Acurx Pharmaceuticals, Inc. Reports Second Quarter 2023 Results and Provides Business Update

Go back to Acurx Pharmaceuticals, Inc. Reports Second Quarter 2023 Results and Provides Business Update

Acurx Pharmaceuticals (ACXP) Misses Q2 EPS by 5c

August 14, 2023 7:13 AM EDT

Acurx Pharmaceuticals (NASDAQ: ACXP) reported Q2 EPS of ($0.28), $0.05 worse than the analyst estimate of ($0.23).

For earnings history and earnings-related data on Acurx Pharmaceuticals (ACXP) click here.

... More